학술논문

Safety and tolerability of obeticholic acid in chronic liver disease: a pooled analysis of 1878 individuals.
Document Type
Article
Source
Hepatology Communications; Mar2023, Vol. 7 Issue 3, p1-9, 9p
Subject
LIVER diseases
FARNESOID X receptor
CHRONIC diseases
RANDOM effects model
CLINICAL trials
Language
ISSN
2471254X
Abstract
Copyright of Hepatology Communications is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)